IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.
| Article Title | Original Publication Date | Journal | Bone Marrow Disease |
|---|---|---|---|
| MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? | Jun 2020 | Best practice & research. Clinical haematology | myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) |
| Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? | Jun 2020 | Best practice & research. Clinical haematology | myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) |
| Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes? | Dec 2012 | Best Pract Res Clin Haematol | myelodysplastic syndromes (MDS) |
| More is better: Combination therapies for myelodysplastic syndromes | Mar 2015 | Best Pract Res Clin Haematol | myelodysplastic syndromes (MDS) |
| Myelodysplastic syndromes (MDS) | Mar 2015 | Best Pract Res Clin Haematol | myelodysplastic syndromes (MDS) |
| When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes? | Dec 2013 | Best Pract Res Clin Haematol | myelodysplastic syndromes (MDS) |
| Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes | Dec 2013 | Best Pract Res Clin Haematol | myelodysplastic syndromes (MDS) |
| Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): Cause or consequence? | Dec 2013 | Best Pract Res Clin Haematol | myelodysplastic syndromes (MDS) |
| Myelodysplastic syndromes: State of the art pathology, diagnosis and management | Dec 2013 | Best Pract Res Clin Haematol | myelodysplastic syndromes (MDS) |
| Revisiting use of growth factors in myelodysplastic syndromes | May 2012 | Asian Pac J Cancer Prev | myelodysplastic syndromes (MDS) |